DiaMedica Therapeutics Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
DiaMedica Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2018 to Q3 2024.
  • DiaMedica Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $7K, unchanged year-over-year.
  • DiaMedica Therapeutics Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $43K, a 53.6% increase year-over-year.
  • DiaMedica Therapeutics Inc. annual Income Tax Expense (Benefit) for 2023 was $43K, a 53.6% increase from 2022.
  • DiaMedica Therapeutics Inc. annual Income Tax Expense (Benefit) for 2022 was $28K, unchanged from 2021.
  • DiaMedica Therapeutics Inc. annual Income Tax Expense (Benefit) for 2021 was $28K, a 3.7% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $43K $7K $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $43K $7K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $43K $7K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $43K $22K +$15K +214% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $28K $7K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $28K $7K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $28K $7K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $28K $7K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $28K $7K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $28K $7K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $28K $7K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $28K $7K $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 $28K $7K +$5K +250% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $23K $7K -$2K -22.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $25K $7K -$2K -22.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $27K $7K +$5K +250% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $22K $2K -$10K -83.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $32K $9K +$1K +12.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $31K $9K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $31K $2K -$4K -66.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-10
Q3 2019 $35K $12K -$45K -78.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $80K $8K -$8K -50% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $88K $9K +$8K +800% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $80K $6K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-23
Q3 2018 $57K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $16K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $1K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.